Le Lézard25m
Akeso Announces The Publication of Its Phase III Clinical Trial Results for Ivonescimab in Head-to-Head Comparison with Pembrolizumab in The Lancet
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the groundbreaking results of the Phase III clinical study (HARMONi-2/AK112-303) of its first-in-class PD-1/VEGF bispecific ...
MedPage Today on MSN6h
AI and Mammography; Breast Cancer and Sexual Well-Being; Malaria Drug for Cancer?
Breast cancer patients who underwent postmastectomy breast reconstruction had lower sexual well-being scores compared with ...
Chemo-immunotherapy approach shows potential benefit in patients with advanced HPV-negative head and neck cancer
Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...
Mirage News8h
Chemo-Immunotherapy Promising for Advanced Head, Neck Cancer
Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including ...
Physician's Weekly16h
Factors Influencing 5-Fluorouracil Response in SCCis Treatment
The following is a summary of “5-fluorouracil 5% cream for squamous cell carcinoma in situ: Factors impacting treatment ...